These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24408161)

  • 1. IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house.
    Anelli L; Zagaria A; Minervini A; Casieri P; Coccaro N; Tota G; Minervini CF; Brunetti C; Impera L; Ricco A; Cellamare A; Specchia G; Albano F
    Ann Hematol; 2014 Sep; 93(9):1605-7. PubMed ID: 24408161
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to ibrutinib in a patient with IgG lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation.
    Castillo JJ; Ghobrial IM; Treon SP
    Leuk Lymphoma; 2016 Nov; 57(11):2699-701. PubMed ID: 26980069
    [No Abstract]   [Full Text] [Related]  

  • 3. Coexistence of gain-of-function JAK2 germ line mutations with JAK2V617F in polycythemia vera.
    Lanikova L; Babosova O; Swierczek S; Wang L; Wheeler DA; Divoky V; Korinek V; Prchal JT
    Blood; 2016 Nov; 128(18):2266-2270. PubMed ID: 27647865
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.
    King RL; Gonsalves WI; Ansell SM; Greipp PT; Frederick LA; Viswanatha DS; He R; Kyle RA; Gertz MA; Kapoor P; Morice WG; Howard MT
    Am J Clin Pathol; 2016 Jun; 145(6):843-51. PubMed ID: 27329639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis.
    Martínez-Avilés L; Besses C; Alvarez-Larrán A; Cervantes F; Hernández-Boluda JC; Bellosillo B
    Haematologica; 2007 Dec; 92(12):1717-8. PubMed ID: 18056003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Masked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia vera.
    Tiong IS; Casolari DA; Nguyen T; Van Velzen MJ; Ambler K; D'Andrea RJ; Ross DM
    Blood Cancer J; 2016 Aug; 6(8):e459. PubMed ID: 27540717
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Relevance of the High Prevalence of MYD88 L265P Mutated Vitreoretinal Lymphoma Identified by Droplet Digital Polymerase Chain Reaction.
    Shi H; Zhou X; Chen B; Xiao J; Li Y; Zhou X; Zhou Q; Chen K; Wang Q
    Ocul Immunol Inflamm; 2021 Apr; 29(3):448-455. PubMed ID: 31603365
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms.
    Varettoni M; Arcaini L; Zibellini S; Boveri E; Rattotti S; Riboni R; Corso A; Orlandi E; Bonfichi M; Gotti M; Pascutto C; Mangiacavalli S; Croci G; Fiaccadori V; Morello L; Guerrera ML; Paulli M; Cazzola M
    Blood; 2013 Mar; 121(13):2522-8. PubMed ID: 23355535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.
    Xu L; Hunter ZR; Yang G; Zhou Y; Cao Y; Liu X; Morra E; Trojani A; Greco A; Arcaini L; Varettoni M; Brown JR; Tai YT; Anderson KC; Munshi NC; Patterson CJ; Manning RJ; Tripsas CK; Lindeman NI; Treon SP
    Blood; 2013 Mar; 121(11):2051-8. PubMed ID: 23321251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nongenetic stochastic expansion of JAK2V617F-homozygous subclones in polycythemia vera?
    Godfrey AL; Nangalia J; Baxter EJ; Massie CE; Kent DG; Papaemmanuil E; Campbell PJ; Green AR
    Blood; 2014 Nov; 124(22):3332-4. PubMed ID: 25414437
    [No Abstract]   [Full Text] [Related]  

  • 11. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.
    Gachard N; Parrens M; Soubeyran I; Petit B; Marfak A; Rizzo D; Devesa M; Delage-Corre M; Coste V; Laforêt MP; de Mascarel A; Merlio JP; Bouabdhalla K; Milpied N; Soubeyran P; Schmitt A; Bordessoule D; Cogné M; Feuillard J
    Leukemia; 2013 Jan; 27(1):183-9. PubMed ID: 22944768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significances of MYD88
    Meng Q; Cao XX; Li J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):578-582. PubMed ID: 28877839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAK2 V617F/C618R mutation in a patient with polycythemia vera: a case study and review of the literature.
    Yoo JH; Park TS; Maeng HY; Sun YK; Kim YA; Kie JH; Cho EH; Song J; Lee KA; Suh B; Choi JR
    Cancer Genet Cytogenet; 2009 Feb; 189(1):43-7. PubMed ID: 19167611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma.
    Manasanch EE; Braylan R; Stetler-Stevenson M; Yuan C; Gounden V; Korde N; Tageja N; Bhutani M; Calvo K; Maric I; Roschewski M; Staudt LM; Landgren O
    Leuk Lymphoma; 2014 Jun; 55(6):1402-3. PubMed ID: 23915224
    [No Abstract]   [Full Text] [Related]  

  • 16. Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera.
    Cherry M; Khawandanah M; Zhao ZJ; Srour S; Ozer H; Selby G; Ghabache B; Al-Kali A
    Ann Hematol; 2015 Apr; 94(4):717-9. PubMed ID: 25380996
    [No Abstract]   [Full Text] [Related]  

  • 17. MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity.
    Schmidt J; Federmann B; Schindler N; Steinhilber J; Bonzheim I; Fend F; Quintanilla-Martinez L
    Br J Haematol; 2015 Jun; 169(6):795-803. PubMed ID: 25819228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful diagnosis of lymphoplasmacytic lymphoma with IgG paraprotein using MYD88 L265P mutation analysis].
    Abe M; Saburi M; Itani K; Kohno K; Soga Y; Kondo Y; Kawano Y; Nakayama T
    Rinsho Ketsueki; 2018; 59(6):695-697. PubMed ID: 29973445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved accuracy of discrimination between IgM multiple myeloma and Waldenström macroglobulinaemia by testing for MYD88 L265P mutations.
    Willenbacher W; Willenbacher E; Brunner A; Manzl C
    Br J Haematol; 2013 Jun; 161(6):902-4. PubMed ID: 23560587
    [No Abstract]   [Full Text] [Related]  

  • 20. B-cell acute lymphoblastic leukemia in JAK2 V617F-positive polycythemia vera.
    Jaitly V; Wang W
    Blood; 2018 Feb; 131(8):941. PubMed ID: 29472375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.